Showing results (1431-1440 of 2,426) with videos related to
Sort By:
Pageof 243
The Journal of Sexual Medicine|May 19, 2025
Cognitive behavioural therapy for sexual concerns during menopause: evaluation of a four session protocolSheryl M Green, Melissa Furtado, Alison K Shea, et al.Atherosclerosis|March 11, 2025
Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNAEliot A Brinton, Robert H Eckel, Daniel Gaudet, et al.Journal of the American College of Cardiology|April 17, 2024
Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective CohortNathan D Wong, Wenjun Fan, Xingdi Hu, et al.Diabetes Care|February 22, 2011
Nontraditional markers of glycemia: associations with microvascular conditionsElizabeth Selvin, Lesley M A Francis, Christie M Ballantyne, et al.Journal of Clinical Lipidology|February 5, 2011
Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive proteinMichael H Davidson, Nicola Abate, Christie M Ballantyne, et al.Hypertension (Dallas, Tex. : 1979)|July 8, 2015
Implications of the Eighth Joint National Committee Guidelines for the Management of High Blood Pressure for Aging Adults: Atherosclerosis Risk in Communities StudyMichael D Miedema, Faye L Lopez, Michael J Blaha, et al.Circulation|June 19, 2015
Circulating Biomarkers and Abdominal Aortic Aneurysm Incidence: The Atherosclerosis Risk in Communities (ARIC) StudyAaron R Folsom, Lu Yao, Alvaro Alonso, et al.Journal of the American Heart Association|October 26, 2022
Temporal Trends in Lipoprotein(a) Concentrations: The Atherosclerosis Risk in Communities StudyMatthew R Deshotels, Caroline Sun, Vijay Nambi, et al.The American Journal of Cardiology|March 4, 2008
Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statinsEvan A Stein, Christie M Ballantyne, Eberhard Windler, et al.Nuclear Medicine Communications|January 1, 1990
Hepatic perfusion index in the diagnosis of overt metastatic colorectal cancerK C Ballantyne, R M Charnley, A C Perkins, et al.Pageof 243